CAG
EW icon

Csenge Advisory Group’s Edwards Lifesciences EW Stock Holding History

Csenge Advisory Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Buy
+6,338
New +$531K 0.02% 432
2024
Q3 		– Sell
-3,515
Closed -$325K – 722
2024
Q2 		$325K Sell
3,515
-14
-0.4% -$1.24K 0.02% 506
2024
Q1 		$337K Sell
3,529
-381
-10% -$32K 0.02% 519
2023
Q4 		$298K Sell
3,910
-2,429
-38% -$169K 0.02% 522
2023
Q3 		$439K Sell
6,339
-2,679
-30% -$215K 0.03% 398
2023
Q2 		$851K Buy
9,018
+546
+6% +$47.5K 0.06% 245
2023
Q1 		$701K Buy
8,472
+51
+0.6% +$4.01K 0.05% 268
2022
Q4 		$628K Sell
8,421
-306
-4% -$23.6K 0.05% 294
2022
Q3 		$721K Buy
8,727
+454
+5% +$43.7K 0.06% 263
2022
Q2 		$787K Sell
8,273
-107
-1% -$11.1K 0.07% 252
2022
Q1 		$986K Buy
8,380
+1,086
+15% +$122K 0.08% 222
2021
Q4 		$764K Sell
7,294
-458
-6% -$53.4K 0.07% 251
2021
Q3 		$870K Buy
7,752
+458
+6% +$52.3K 0.07% 245
2021
Q2 		$764K Buy
7,294
+4,301
+144% +$405K 0.07% 252
2021
Q1 		$257K Sell
2,993
-98
-3% -$8.29K 0.03% 419
2020
Q4 		$282K Sell
3,091
-75
-2% -$6.22K 0.03% 343
2020
Q3 		$249K Sell
3,166
-55
-2% -$4.29K 0.03% 330
2020
Q2 		$223K Buy
+3,221
New +$229K 0.03% 329
2018
Q4 		– Sell
-417
Closed -$20K – 591
2018
Q3 		$20K Sell
417
-3,900
-90% -$191K 0.01% 392
2018
Q2 		$211K Buy
+4,317
New +$201K 0.08% 236

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Csenge Advisory Group's EW Position: Q2 2026 in Review

Csenge Advisory Group opened a new position in Edwards Lifesciences (EW) in Q2 2026: 6,338 shares worth $573K. The stake represents 0.02% of the portfolio and ranks #432 among its holdings. This is a return to the name: Csenge Advisory Group previously reported a position in EW as recently as Q2 2024.

Csenge Advisory Group first reported a position in EW in Q2 2018 and has held it in 20 quarters since. The position peaked at $986K in Q1 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Csenge Advisory Group held 6,338 shares of Edwards Lifesciences worth $573K as of Q2 2026.
  • Edwards Lifesciences was a new Csenge Advisory Group position in Q2 2026.
  • Edwards Lifesciences made up 0.02% of Csenge Advisory Group's portfolio in Q2 2026, its #432 holding.
  • Csenge Advisory Group first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 20 quarters since.
  • Csenge Advisory Group's Edwards Lifesciences position peaked at $986K in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.